Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.28
1.63%
After-hours: Aug 15, 2025, 07:36 PM EDT
Psyence Biomedical Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | n/a | -632.1K | -557.05K | -512.09K | -771.49K | -510.93K | -163.13K | -293.02K | -326.9K | -254.8K | -45.06K |
Interest Income | n/a | n/a | n/a | 187.84K | 485.6K | 2.63M | 799.27K | 115.55K | 6.29K | 2.42K | n/a |
Pretax Income | 141.47K | -24.76M | -647.77K | -62.84K | -24.49K | 2.25M | 766.84K | 2.04M | 2.95M | 8.31M | -45.06K |
Net Income | 141.47K | -24.76M | -647.77K | -62.84K | -24.49K | 2.25M | 766.84K | 2.04M | 2.95M | 8.31M | -45.06K |
Selling & General & Admin | 890.48K | 556.97K | 557.05K | 512.09K | 771.49K | 510.93K | 163.13K | 293.02K | 326.9K | 254.79K | 45.06K |
Research & Development | 265.63K | 75.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 1.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 1.16M | 632.1K | 557.05K | 512.09K | 771.49K | 510.93K | 163.13K | 293.02K | 326.9K | 254.79K | 45.06K |
Interest Expense | 3.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 273.77K | 39.22K | 1.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.16M | 632.1K | 557.05K | 512.09K | 771.49K | 510.93K | 163.13K | 293.02K | 326.9K | 254.79K | 45.06K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 276.73K | 13.39M | 7.69M | 8.04M | 11.43M | 32.67M | 28.54M | 28.54M | 28.54M | 32.67M | 32.75M |
Shares Outstanding (Diluted) | 276.73K | 13.39M | 7.69M | 8.04M | 11.43M | 32.67M | 28.54M | 28.54M | 28.54M | 32.67M | 32.75M |
EPS (Basic) | 38.35 | -1.85 | -0.08 | -0.01 | -0.00 | 0.07 | 0.03 | 0.07 | 0.10 | 0.25 | -0.00 |
EPS (Diluted) | 38.34 | -1.85 | -0.08 | -0.01 | -0.00 | 0.07 | 0.03 | 0.07 | 0.10 | 0.25 | -0.00 |
EBITDA | 146.2K | -632.1K | -557.05K | -512.09K | -771.49K | -510.93K | -163.13K | -293.02K | -326.9K | -254.8K | -45.06K |
EBIT | 145.19K | -632.22K | -173.85K | -62.84K | -24.49K | -1.3M | -244K | 2.04M | 2.95M | 8.31M | -45.06K |
Depreciation & Amortization | 1.02K | 120.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |